Refining Strategies for Enhancing Cardiorenal Outcomes with SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
December 03, 2024
01:30 PM - 02:30 PM EST
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care
December 05, 2024
12:00 PM - 01:30 PM EST